
Meera Natarajan
Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643 |
| Total Applications | 1062 |
| Issued Applications | 625 |
| Pending Applications | 87 |
| Abandoned Applications | 376 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4669779
[patent_doc_number] => 20080044839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Methods and compositions for diagnosing lung cancer'
[patent_app_type] => utility
[patent_app_number] => 11/715642
[patent_app_country] => US
[patent_app_date] => 2007-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 41543
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044839.pdf
[firstpage_image] =>[orig_patent_app_number] => 11715642
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/715642 | Methods and compositions for diagnosing lung cancer | Mar 7, 2007 | Issued |
Array
(
[id] => 5434986
[patent_doc_number] => 20090169572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-CDH3 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/280956
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14797
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169572.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280956
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280956 | METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-CDH3 ANTIBODIES | Feb 27, 2007 | Abandoned |
Array
(
[id] => 5125844
[patent_doc_number] => 20070238115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Method of Diagnosing and Treating Colon Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/679258
[patent_app_country] => US
[patent_app_date] => 2007-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14794
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238115.pdf
[firstpage_image] =>[orig_patent_app_number] => 11679258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/679258 | Method of Diagnosing and Treating Colon Cancer | Feb 26, 2007 | Abandoned |
Array
(
[id] => 5004474
[patent_doc_number] => 20070202042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/709457
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19037
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709457 | Cancerous disease modifying antibodies | Feb 21, 2007 | Issued |
Array
(
[id] => 132235
[patent_doc_number] => 07700751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Humanized antibodies that recognize β-amyloid peptide'
[patent_app_type] => utility
[patent_app_number] => 11/707639
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 42504
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 47
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700751.pdf
[firstpage_image] =>[orig_patent_app_number] => 11707639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/707639 | Humanized antibodies that recognize β-amyloid peptide | Feb 15, 2007 | Issued |
Array
(
[id] => 5112961
[patent_doc_number] => 20070196876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Free NGAL as a biomarker for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/707749
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9916
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11707749
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/707749 | Free NGAL as a biomarker for cancer | Feb 15, 2007 | Abandoned |
Array
(
[id] => 5027987
[patent_doc_number] => 20070269434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'TAT-041 and methods of assessing and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/700378
[patent_app_country] => US
[patent_app_date] => 2007-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 64623
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269434.pdf
[firstpage_image] =>[orig_patent_app_number] => 11700378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/700378 | TAT-041 and methods of assessing and treating cancer | Jan 30, 2007 | Abandoned |
Array
(
[id] => 5131677
[patent_doc_number] => 20070208074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Methods and compositions for treating and preventing tumors'
[patent_app_type] => utility
[patent_app_number] => 11/657965
[patent_app_country] => US
[patent_app_date] => 2007-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14579
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20070208074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11657965
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/657965 | Methods and compositions for treating and preventing tumors | Jan 23, 2007 | Abandoned |
Array
(
[id] => 5258760
[patent_doc_number] => 20070212392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Chemoprevention of endometrial cancer'
[patent_app_type] => utility
[patent_app_number] => 11/655895
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6230
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11655895
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/655895 | Chemoprevention of endometrial cancer | Jan 21, 2007 | Issued |
Array
(
[id] => 809627
[patent_doc_number] => 07416725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-26
[patent_title] => 'Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth'
[patent_app_type] => utility
[patent_app_number] => 11/612910
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14295
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/416/07416725.pdf
[firstpage_image] =>[orig_patent_app_number] => 11612910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612910 | Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth | Dec 18, 2006 | Issued |
Array
(
[id] => 62266
[patent_doc_number] => 07763245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-27
[patent_title] => 'Methods and compositions for targeting polyubiquitin'
[patent_app_type] => utility
[patent_app_number] => 11/611058
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 57
[patent_no_of_words] => 54526
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/763/07763245.pdf
[firstpage_image] =>[orig_patent_app_number] => 11611058
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611058 | Methods and compositions for targeting polyubiquitin | Dec 13, 2006 | Issued |
Array
(
[id] => 103119
[patent_doc_number] => 07723484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Anti-EGFR antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/090395
[patent_app_country] => US
[patent_app_date] => 2006-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12309
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723484.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090395 | Anti-EGFR antibodies | Nov 5, 2006 | Issued |
Array
(
[id] => 5148263
[patent_doc_number] => 20070048322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/590434
[patent_app_country] => US
[patent_app_date] => 2006-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20753
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048322.pdf
[firstpage_image] =>[orig_patent_app_number] => 11590434
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/590434 | Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis | Oct 30, 2006 | Issued |
Array
(
[id] => 5022202
[patent_doc_number] => 20070148168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions'
[patent_app_type] => utility
[patent_app_number] => 11/588973
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24071
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11588973
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/588973 | Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions | Oct 26, 2006 | Abandoned |
Array
(
[id] => 5154321
[patent_doc_number] => 20070037204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Gene overexpressed in cancer'
[patent_app_type] => utility
[patent_app_number] => 11/584793
[patent_app_country] => US
[patent_app_date] => 2006-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 55144
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037204.pdf
[firstpage_image] =>[orig_patent_app_number] => 11584793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/584793 | Gene overexpressed in cancer | Oct 19, 2006 | Abandoned |
Array
(
[id] => 5050891
[patent_doc_number] => 20070031436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Multivalent antibody contructs'
[patent_app_type] => utility
[patent_app_number] => 11/546262
[patent_app_country] => US
[patent_app_date] => 2006-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4858
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11546262
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/546262 | Multivalent antibody constructs | Oct 9, 2006 | Issued |
Array
(
[id] => 4994167
[patent_doc_number] => 20070009512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains'
[patent_app_type] => utility
[patent_app_number] => 11/520128
[patent_app_country] => US
[patent_app_date] => 2006-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11386
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11520128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/520128 | Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains | Sep 12, 2006 | Abandoned |
Array
(
[id] => 4988141
[patent_doc_number] => 20070154480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Humanized antibodies that recognize beta amyloid peptide'
[patent_app_type] => utility
[patent_app_number] => 11/520438
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 42640
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154480.pdf
[firstpage_image] =>[orig_patent_app_number] => 11520438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/520438 | Humanized antibodies that recognize beta amyloid peptide | Sep 11, 2006 | Issued |
Array
(
[id] => 4733388
[patent_doc_number] => 20080050367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Humanized antibodies that recognize beta amyloid peptide'
[patent_app_type] => utility
[patent_app_number] => 11/516724
[patent_app_country] => US
[patent_app_date] => 2006-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 42687
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050367.pdf
[firstpage_image] =>[orig_patent_app_number] => 11516724
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/516724 | Humanized antibodies that recognize beta amyloid peptide | Sep 4, 2006 | Abandoned |
Array
(
[id] => 5182985
[patent_doc_number] => 20070054332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Syndecan 1 ectodomain inhibits cancer'
[patent_app_type] => utility
[patent_app_number] => 11/501209
[patent_app_country] => US
[patent_app_date] => 2006-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16793
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054332.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501209
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501209 | Syndecan 1 ectodomain inhibits cancer | Aug 7, 2006 | Abandoned |